Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cardiovascular | rythm | | |
selective targeting of PLCbeta1b splice variant to the sarcolemma provides a potential therapeutic target to reduce hypertrophy, apoptosis, and arrhythmias. | cardiovascular | valvulopathy | | |
activation of PLCbeta1b is a possible therapeutic target to limit atrial remodelling in mitral valve disease patients | cardiovascular | cardiomyopathy | | |
preventing PLCbeta1b association with the sarcolemma may provide a useful therapeutic target to limit hypertrophy |
| | | |